Steve W Cole Selected Research

Adrenergic Agents (Adrenergic Drugs)

7/2020	Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells.
1/2020	Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial.
1/2019	Transcriptomic predictors of inflammation-induced depressed mood.
1/2019	Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.
1/2019	C/EBPβ regulates the M2 transcriptome in β-adrenergic-stimulated macrophages.
1/2018	Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
1/2018	Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.
8/2017	Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens.
10/2015	Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.
2/2015	Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steve W Cole Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 11/2007
28	Inflammation (Inflammations) 08/2022 - 05/2006
19	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2006
12	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2007
10	Fatigue 08/2022 - 05/2006
9	Infections 01/2021 - 03/2003
7	Carcinoma (Carcinomatosis) 01/2021 - 11/2008
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2015
3	Virus Diseases (Viral Diseases) 11/2021 - 08/2007
3	Ascites 01/2021 - 02/2011
3	Ovarian Epithelial Carcinoma 01/2019 - 10/2015
2	Leukemia 08/2022 - 12/2019
2	Multiple Myeloma 11/2020 - 05/2018
2	Birth Weight (Birth Weights) 12/2019 - 12/2019
2	Disease Progression 01/2015 - 06/2008
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2008 - 11/2005
1	Pain (Aches) 08/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Bacterial Infections (Bacterial Infection) 10/2019
1	Body Weight (Weight, Body) 10/2019
1	Depressive Disorder (Melancholia) 01/2019
1	HIV Infections (HIV Infection) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 05/2018
1	Hypotension (Low Blood Pressure) 05/2018
1	Asthma (Bronchial Asthma) 01/2018

Drug/Important Bio-Agent (IBA)

17	Adrenergic Agents (Adrenergic Drugs)IBA 07/2020 - 11/2005
14	CytokinesIBA 08/2022 - 05/2006
13	Biological ProductsIBA 02/2021 - 01/2009
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2006
9	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 11/2005
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2007
7	CatecholaminesIBA 01/2020 - 11/2005
6	Interferon Type IIBA 11/2021 - 03/2005
6	Transcription Factors (Transcription Factor)IBA 11/2021 - 06/2009
6	Propranolol (Inderal)FDA LinkGeneric 11/2020 - 04/2009
5	Antiviral Agents (Antivirals)IBA 11/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2004
5	NF-kappa B (NF-kB)IBA 01/2021 - 03/2005
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021 - 03/2005
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 03/2007
3	Hormones (Hormone)IBA 01/2021 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 06/2011
3	LipopolysaccharidesIBA 10/2019 - 05/2006
3	GlucocorticoidsIBA 01/2019 - 03/2007
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 02/2008
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2013 - 11/2005
3	Epinephrine (Adrenaline)FDA LinkGeneric 02/2011 - 11/2005
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2022 - 05/2006
2	C-Reactive ProteinIBA 01/2021 - 09/2011
2	Liposomes (Liposome)IBA 01/2021 - 11/2007
2	LuciferasesIBA 01/2021 - 05/2012
2	EnzymesIBA 01/2021 - 01/2015
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2021 - 01/2019
2	InterleukinsIBA 01/2021 - 05/2006
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2018
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2019 - 12/2019
2	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2018 - 05/2012
2	Caffeine (No Doz)FDA LinkGeneric 10/2015 - 02/2011
2	Small Interfering RNA (siRNA)IBA 02/2015 - 11/2007
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2015 - 11/2007
2	Dopamine Receptors (Dopamine Receptor)IBA 05/2013 - 06/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 02/2009 - 03/2003
2	Matrix Metalloproteinases (MMPs)IBA 11/2008 - 11/2007
2	Immunoglobulin G (IgG)IBA 07/2008 - 07/2008
1	tocilizumab (atlizumab)FDA Link 08/2022
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	AntigensIBA 01/2021
1	Clodronic Acid (Clodronate)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2021
1	Interferon Regulatory FactorsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 11/2020
1	NitrogenIBA 10/2020
1	ProstaglandinsIBA 01/2020
1	Lipocalin-2IBA 10/2019
1	Sucrose (Saccharose)IBA 10/2019
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2019
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2019
1	EndotoxinsIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 05/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	ElementsIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	erythromycin propionate-N-acetylcysteinateIBA 01/2018

Therapy/Procedure

9	Therapeutics 01/2022 - 05/2006
6	Drug Therapy (Chemotherapy) 01/2021 - 09/2011
4	Aftercare (After-Treatment) 01/2021 - 01/2018
3	Meditation 01/2021 - 03/2013
3	Radiotherapy 01/2021 - 06/2013
2	Neoadjuvant Therapy 01/2021 - 01/2019
2	Cell Transplantation 12/2019 - 05/2018
1	Kidney Transplantation 01/2021
1	Bariatric Surgery 01/2021